In 2023, Andrew Robbins earned $1.06M in total compensation at Cogent Biosciences, Inc., including $656.10K salary and $393.66K bonus. 5+ years at the helm of Cogent Biosciences, Inc..
Compensation History
Annual executive compensation data for Andrew Robbins, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.06M
Salary
$656.10K
Bonus
$393.66K
Other
$13.20K
Salary
$656.10KBoard Justification
The compensation philosophy targets the 50th percentile of peer group compensation, aligning with company performance and retention strategies.
Bonus
$393.66KBoard Justification
Cash bonuses for the 2023 performance year were funded at 125% of target based on achievement of nearly all target and stretch goals in 2023.
Other Compensation
$13.20KBoard Justification
Represents the value of 401(k) contributions made by the Company.
Restricted Stock
Board Justification
No stock was reported as vested in 2023.
Performance Metrics
Cash bonuses are based on company performance against established goals.
Andrew Robbins
CEO of Cogent Biosciences, Inc.
Education
MBA from the Kellogg School of Management, Northwestern University and a bachelor’s degree from Swarthmore College
Sector of Economy
Healthcare
CEO of Cogent Biosciences, Inc. for
5 years 1 month (Oct 2020 - Present)
Previous Experience
Chief Operating Officer at Array BioPharma Inc.
Other Cogent Biosciences, Inc. CEOs
Holdings
Track Andrew Robbins's stock holdings and portfolio value over time.
Insider Trading
Andrew Robbins's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Andrew Robbins with competitor CEOs and industry peers.